Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ironwood Pharmaceuticals, Inc.
About IRWD
Ironwood Pharmaceuticals, Inc. is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI), and rare diseases. It is focused on the development and commercialization of GI product opportunities in areas of significant unmet need. LINZESS (linaclotide), its commercial product, is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC), and for pediatric patients ages 6-17 years-old suffering from functional constipation (FC). Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC and pediatric patients. The Company is also engaged in advancing apraglutide, a synthetic long-acting peptide analog of glucagon-like peptide-2 (GLP-2), for short bowel syndrome (SBS), patients who are dependent on parenteral support.
Find out what a historical investment in Ironwood Pharmaceuticals, Inc. would be worth today using our IRWD stock calculator.
Market Capitalisation
$600.84M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.87M
High today
$3.70
Low today
$3.58
Open price
$3.65
52-week high
$5.78
52-week low
$0.61
Ready to start your investing journey with Stake?
Open an accountHow do I buy IRWD shares in Australia?
Buying IRWD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ironwood Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IRWD
What is the ticker symbol of Ironwood Pharmaceuticals, Inc.?
The ticker symbol for Ironwood Pharmaceuticals, Inc. is IRWD.
How much is one share of IRWD?
One share of IRWD is valued at $3.64 as of 13 June 2026.
What is the market capitalisation of Ironwood Pharmaceuticals, Inc. IRWD?
As of 13 June 2026 Ironwood Pharmaceuticals, Inc. has a market cap of $600.84M.
What is the P/E ratio of IRWD?
The Price to Earnings ratio of IRWD is 6.21.
What is the Earnings Per Share of IRWD?
The Earnings Per Share of IRWD is $0.58.
What is the 52-week high for Ironwood Pharmaceuticals, Inc. stock?
The Ironwood Pharmaceuticals, Inc. 52-week high stock price is $5.78.
What is the 52-week low for Ironwood Pharmaceuticals, Inc. stock?
The Ironwood Pharmaceuticals, Inc. 52-week low stock price is $0.61.
Can I buy IRWD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IRWD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IRWD on Stake
- Buy IRWD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of IRWD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
IRWD related stocks